Introduction
Calcium channel blocker (CCB) therapy has an established role in the treatment of hypertension, 1 but in a small proportion of patients, the side effect profile of these drugs may limit their use. The commonest clinical adverse effects include ankle swelling, flushing, headache, palpitations and constipation. 2 We describe an unusual case where ankle swelling was associated with bilateral achilles tendonitis.
Case report
A 50-year-old Caucasian male electronics engineer, presented to the hypertension clinic with a 3-year history of documented essential hypertension. The blood pressure was 150-156/100-102 mm Hg and there was evidence of grade 1 hypertensive retinopathy, dipstick positive proteinuria and a serum creatinine of 118 M/L. Echocardiography confirmed the presence of mild concentric left ventricular hypertrophy. Additional cardiovascular risk factors included hypercholesterolaemia (total cholesterol 5.9 mM/L, calculated LDL 4.0 mM/L). He was a nonsmoker with a fasting glucose of 5.3 mM/L. There was no past history of ischaemic heart disease, heart failure or any rheumatological conditions.
The patient complained of feeling lethargic on his antihypertensive medication (atenolol 50 mg once a day) and so this was slowly withdrawn. The blood pressure after 3 weeks had increased to 162-175/106-109 mm Hg and he therefore commenced amlodipine which was gradually increased, over a period of 6 months, to a maximum of 10 mg a day. Within 2 weeks of receiving amlodipine 10 mg a day, the blood pressure had reduced to 142-146/93-97 mm Hg. However, the patient noted point tenderness over both achilles tendons with mild swelling of both ankles (Figure 1 ). These features were associated with pain on walking and consequently the patient elected to stop taking the medication. There had been no concomitant weight change or shortness of breath while receiving treatment with amlodipine. Within 10 days of drug withdrawal the ankle swelling and tendon pain resolved completely but his blood pressure control deteriorated (BP 157-183/105-115 mm Hg).
To confirm that this was a drug associated effect, the patient agreed to restart amlodipine. Within 3 weeks there was recurrence of his symptoms with bilateral achilles tendon pain and ankle swelling. Ultrasound of the ankles confirmed the presence of achilles tendon thickening, with evidence of hyperaemia on colour Doppler imaging consistent with acute tendonitis (Figure 2) . Further investigations confirmed an ESR of 11 mm/h, and a negative rheumatoid factor titre of Ͻ1:40. His symptoms resolved after a further withdrawal of amlodipine therapy. Alternative antihypertensive medication was then initiated. 
Discussion
Achilles tendonitis is a well-described clinical condition commonly associated with sporting activity such as running 3 or occupational injury. 4 Inflammatory disorders such as psoriatic arthropathy, Reiter's syndrome and sarcoidosis may also present with achilles tendonitis. 5, 6 . None of these associations were found in our patient.
Drug induced achilles tendonitis has not been previously reported with CCB therapy but may be associated with painful ankle oedema. Few drugs, namely the fluoroquinolone group of antibiotics 7 and isotretinoin, 8 have been associated with achilles tendonitis which in some cases may lead to acute tendon rupture. It would therefore be wise to discontinue amlodipine therapy in cases associated with painful ankle swelling as this may be indicative of achilles tendonitis.
